Amgen Net Income Applicable To Common Shares from 2010 to 2026
| AMGN Stock | 28.58 0.73 2.62% |
Net Income Applicable To Common Shares | First Reported 2010-12-31 | Previous Quarter 7.7 B | Current Value 6.9 B | Quarterly Volatility 685.2 M |
Check Amgen CDR financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amgen CDR's main balance sheet or income statement drivers, such as Tax Provision of 1 B, Interest Income of 695.4 M or Selling General Administrative of 7 B, as well as many indicators such as . Amgen financial statements analysis is a perfect complement when working with Amgen CDR Valuation or Volatility modules.
Amgen | Net Income Applicable To Common Shares |
Evaluating Amgen CDR's Net Income Applicable To Common Shares across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Amgen CDR's fundamental strength.
Latest Amgen CDR's Net Income Applicable To Common Shares Growth Pattern
Below is the plot of the Net Income Applicable To Common Shares of Amgen CDR over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Amgen CDR's Net Income Applicable To Common Shares historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amgen CDR's overall financial position and show how it may be relating to other accounts over time.
| Net Income Applicable To Common Shares | 10 Years Trend |
|
Net Income Applicable To Common Shares |
| Timeline |
Amgen Net Income Applicable To Common Shares Regression Statistics
| Arithmetic Mean | 6,505,191,176 | |
| Geometric Mean | 6,462,979,245 | |
| Coefficient Of Variation | 10.53 | |
| Mean Deviation | 284,140,138 | |
| Median | 6,552,000,000 | |
| Standard Deviation | 685,193,264 | |
| Sample Variance | 469489.8T | |
| Range | 3.6B | |
| R-Value | (0.06) | |
| Mean Square Error | 499222.9T | |
| R-Squared | 0 | |
| Significance | 0.83 | |
| Slope | (7,588,235) | |
| Total Sum of Squares | 7511836.9T |
Amgen Net Income Applicable To Common Shares History
About Amgen CDR Financial Statements
Amgen CDR investors utilize fundamental indicators, such as Net Income Applicable To Common Shares, to predict how Amgen Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Income Applicable To Common Shares | 7.7 B | 6.9 B |
Pair Trading with Amgen CDR
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amgen CDR position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen CDR will appreciate offsetting losses from the drop in the long position's value.Moving against Amgen Stock
| 0.59 | DR | Medical Facilities | PairCorr |
| 0.59 | HSTR | Heliostar Metals | PairCorr |
| 0.53 | PJX | PJX Resources | PairCorr |
| 0.52 | GMA | Geomega Resources | PairCorr |
| 0.51 | AUUA | Aluula Composites Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Amgen CDR could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amgen CDR when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amgen CDR - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amgen CDR to buy it.
The correlation of Amgen CDR is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amgen CDR moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amgen CDR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amgen CDR can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Amgen Stock
Amgen CDR financial ratios help investors to determine whether Amgen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Amgen with respect to the benefits of owning Amgen CDR security.